Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (September 2017)

Tuesday, October 24, 2017

Between January and September 2017, Russian manufacturers produced and dispatched 241.3 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 7.2% higher than that of the same period of 2016. In physical terms, the dispatch volume amounted 3.08 bln units, which is only 2.1% higher than that of the same period of 2016.

The September performance is not that impressive. Russian manufacturers produced and dispatched 28.9 bln RUB worth of pharmaceuticals, which is 4% lower than that of September 2016. In physical terms, the dynamics are also negative (-1.4%), with 0.35 bln units. On the one hand, it is due to the high August performance, as distributors had no interest in overstocking their warehouses in the current economic circumstances. On the other hand, it is obvious that Russian companies need additional incentives for development.

In monetary terms, the dispatch dynamics for the period between January and September 2015 turned out lower than that of the import. Russia imported 372.2 bln RUB worth of ready-made drugs (customs clearance included), which is 9% higher than that of the same period of 2016. In physical terms, the dynamics are 6.5%, with 1.47 bln units.

Read more aboutDispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (August 2017) here:http://rncph.com/news/20_09_2017

Dynamics of dispatch volumes of pharmaceutical drugs from Russian manufacturers, in physical (units) and monetary terms (RUB, VAT included) (January 2016 – September 2017)

Share: